Clinical trial
Prospective Study on Intensive Early Rheumatoid Arthritis Treatment
NCT00480272 · Fondazione IRCCS Policlinico San Matteo di Pavia, Other · Completed
Key facts
| NCT number | NCT00480272 |
|---|---|
| Title | Prospective Study on Intensive Early Rheumatoid Arthritis Treatment |
| Official title | A Phase IV Multicenter, Randomized, Double-blind Study. prospeCtive Study on Intensive Early Rheumatoid Arthritis Treatment With adalimUmab: Induction of REmission and Maintenance |
| Acronym | CURE |
| Lead sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | adalimumab, plus prednisone, adalimumab plus placebo |
| Enrollment | 251 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2017 |
| Completion | Mar 1, 2017 |
| First posted | May 30, 2007 |
| Last update posted | Mar 6, 2017 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: